Mary Lee

Mary Lee serves as a Contracting Officer responsible for managing complex procurements within a federal agency focused on critical health and industrial infrastructure. She oversees the full lifecycle of contract actions—from market research and solicitation development to award and closeout—ensuring strict compliance with the Federal Acquisition Regulation (FAR). Her portfolio centers on high-stakes acquisitions requiring technical precision and regulatory adherence, particularly in pharmaceutical manufacturing and heavy-gauge metal fabrication. Mary ensures all procurements align with agency mission objectives while maintaining transparency, fairness, and accountability in sourcing decisions. While specific contractor names are not publicly identifiable in available records, Mary cultivates relationships with a diverse pool of vendors capable of meeting stringent quality, safety, and compliance standards in pharmaceutical preparation and industrial tank manufacturing. She engages both large-capacity manufacturers and specialized small businesses, fostering competitive bidding environments that prioritize technical capability, past performance, and regulatory conformity. Her approach emphasizes long-term vendor reliability over transactional engagements, encouraging consistent performance and supply chain resilience. Mary demonstrates a clear preference for non-set-aside acquisitions, with 80% of her awards issued under full and open competition. However, she actively supports small business participation through Total Small Business Set-Asides under FAR 19.5, consistently reserving 20% of her contracting actions for qualified small businesses. Her socioeconomic strategy reflects a balanced commitment to both broad market access and targeted opportunities for small business growth, without reliance on specialized set-asides such as 8(a), HUBZone, or SDVOSB programs. Her procurement focus is overwhelmingly concentrated in NAICS 325412 (Pharmaceutical Preparation Manufacturing), where she procures sterile injectables, solid-dose formulations, and associated packaging systems requiring cGMP compliance. She also manages acquisitions in NAICS 332420 (Metal Tank [Heavy Gauge] Manufacturing), sourcing industrial storage vessels and pressure-rated containment systems used in chemical and pharmaceutical processing. This dual specialization underscores her technical fluency in regulated manufacturing environments and her ability to navigate complex supply chains involving hazardous materials and controlled environments.